Crossmark

Lenalidomide ameliorates cognitive impairment via putative AChE inhibition: an in silico and in vivo study in a scopolamine-induced cognitive impairment model

Crossref DOI link: https://doi.org/10.1038/s41598-026-49461-8

Published Online: 2026-05-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sheikh, Salehin

Shadin, Md.

Eity, Tanzila Akter

Oni, Most. Israt Jahan

Khatun, Mst Muslima

Chowdhury, Raihan

Bhuia, Md. Shimul

Alfaifi, Mohammed

Altemani, Faisal H.

Altemani, Abdullah H.

Saleh, Na’il

Islam, Muhammad Torequl
Funding

Funding for this research was provided by:

United Arab Emirates University
License Information

Text and Data Mining valid from 2026-05-23

Accepted Manuscript valid from 2026-05-23
More Information

Article History

Received: 4 October 2025

Accepted: 15 April 2026

First Online: 23 May 2026

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below